Long intergenic non-protein coding RNA 2049 (LINC02049)

Long intergenic non-protein coding RNA 2049 (LINC02049) is a non-coding RNA gene producing a long RNA transcript, located in the intergenic regions of the human genome and does not overlap with annotated protein-coding genes[1]. Like other lincRNAs, it is presumed to play roles in regulation of gene expression at multiple levels (including transcriptional and post-transcriptional regulation) but its specific molecular function and biological significance remain uncharacterized[3][5]. LINC02049 is not mapped as a therapeutic target, biomarker, or receptor and no known drugs interact with it directly[1]. Research into lincRNAs broadly has linked some family members to disease progression, especially in cancer, via modulation of microRNA availability and disruption of signaling pathways that control cell proliferation, apoptosis, and migration[3][5]. However, such evidence has not been established for LINC02049 itself. Most available resources, including GeneCards, describe LINC02049 as an annotated non-coding RNA with limited functional characterization and no established links to specific diseases, pharmacological compounds, or clinical biomarkers[1][3][5]. This makes it a poorly characterized non-coding RNA gene, with potential importance awaiting experimental validation.

Other names

LOC105374069LINC02049